Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,971	14,014	10,008	14,112	15,526	-
Market Cap Growth	47.22%	40.02%	-29.08%	-9.10%	-	-
Enterprise Value	16,690	12,658	9,443	13,028	13,956	-
Last Close Price	67.89	52.94	41.70	58.80	64.69	-
Forward PE	-	35.51	35.51	-	-	-
PS Ratio	36.77	36.26	33.11	74.13	561.28	-
PB Ratio	13.79	8.52	12.71	11.26	9.18	-
P/TBV Ratio	14.55	8.96	14.98	13.07	10.43	-
EV/Sales Ratio	34.17	32.75	31.24	68.44	504.55	-
Debt / Equity Ratio	0.71	0.54	0.70	0.18	0.03	0.88
Asset Turnover	0.17	0.17	0.18	0.10	0.02	-
Inventory Turnover	0.27	0.30	0.36	0.19	0.04	0.04
Quick Ratio	1.79	2.08	1.57	3.35	11.37	0.53
Current Ratio	1.95	2.22	1.77	3.69	11.85	0.68
Return on Equity (ROE)	-12.48%	-24.27%	-47.59%	-31.38%	-35.20%	-252.11%
Return on Assets (ROA)	-6.50%	-10.91%	-19.70%	-17.02%	-20.80%	-73.37%
Return on Capital (ROIC)	-7.84%	-12.84%	-23.92%	-19.64%	-25.32%	-133.90%
Earnings Yield	-0.97%	-1.99%	-4.57%	-3.20%	-2.06%	-
FCF Yield	-0.12%	-2.11%	-4.59%	-3.72%	-2.59%	-
Buyback Yield / Dilution	-6.08%	-6.74%	0.19%	-2.20%	-30.61%	95.55%
Total Shareholder Return	-6.08%	-6.74%	0.19%	-2.20%	-30.61%	95.55%

Source: S&P Capital IQ. Standard template. Financial Sources.